News
Inflammatix in the news
Inflammatix Aims for 2024 Launch of 30-Minute Sepsis and Acute Infection Test
November 28, 2023
Your medical devices are getting smarter. Can the FDA keep them safe?
October 9, 2023
Point-of-care testing for infectious diseases in emergency settings
January 18, 2023
Do Your Genes Know What’s Making You Sick?
January 6, 2022
Artificial Intelligence for Clinical Decision Support in Sepsis
May 13, 2021
Inflammatix Checks off All the Right Boxes with Investors
March 19, 2021
Inflammatix nets $102M to advance its immune system tests for infectious diseases
March 16, 2021
Infection-detection system from Peninsula company scores $102M, aims to hit market this year
March 16, 2021
A Bright Future Ahead for Novel Markers of Infection
December 15, 2020
Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test
October 29, 2020
Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform
October 8, 2020
Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk
September 30, 2020